Home » Insmed Provides Update on Muscular Dystrophy Programs
Insmed Provides Update on Muscular Dystrophy Programs
Insmed’s Phase 2 trial of IPLEX in Myotonic Muscular Dystrophy (MMD), which was initiated in December 2007, has seen a strong patient and physician interest and is now fully enrolled.
CNN Money
CNN Money
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May